Surgical management of non-small-cell lung cancer

被引:0
|
作者
Bamousa, Ahmed [1 ]
AlKattan, Khaled [2 ]
机构
[1] Riyadh Mil Hosp, Dept Surg, Riyadh 11159, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia
关键词
Lung cancer; surgery; staging;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Surgery plays a major role in the management of patients with lung cancer. Surgery is not only the main curative treatment modality in patients with early-stage lung cancer but it also has a significant role in the initial workup for the diagnosis and staging of lung cancer. This article describes the surgical management of patients with lung cancer. Surgical resection for lung cancer is still regarded as the most effective method for controlling the primary tumor, provided it is resectable for cure and the risks of the procedure are low. The 5-year survival rare following complete resection (R0) of a lung cancer is stage dependent [Table 1]. ([1-3]) Incomplete resection (R1, R2) rarely, if ever, cures the patient.
引用
收藏
页码:S82 / S88
页数:7
相关论文
共 50 条
  • [41] Role of Cytology in the Management of Non-Small-Cell Lung Cancer.
    Fischer, Andrew H.
    Cibas, Edmund S.
    Howell, Lydia P.
    Kurian, Elizabeth M.
    Laucirica, Rodolfo
    Moriarty, Ann T.
    Renshaw, Andrew A.
    Zakowski, Maureen F.
    Young, Nancy A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3331 - 3332
  • [42] The clinical role of cetuximab in the management of non-small-cell lung cancer
    Ibrahim, Ezzeldin M.
    Al-Fayea, Turki M.
    Kazkaz, Ghieth A.
    [J]. LUNG CANCER MANAGEMENT, 2012, 1 (01) : 3 - 5
  • [43] SEOM guidelines for the management of non-small-cell lung cancer (NSCLC)
    Enriqueta Felip
    Pilar Garrido
    José Manuel Trigo
    Marta López-Brea
    Luis Paz-Ares
    Mariano Provencio
    Dolores Isla
    [J]. Clinical and Translational Oncology, 2009, 11 : 284 - 289
  • [44] Controversies in the management of stage III non-small-cell lung cancer
    Biswas, Tithi
    Sharma, Neelesh
    Machtay, Mitchell
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (03) : 333 - 347
  • [45] Use of PET in the management of non-small-cell lung cancer in Canada
    Vorauer, E.
    Louzado, C.
    DeCaria, K.
    Hernandez, J.
    Rahal, R.
    Niu, J.
    Lockwood, G.
    Bryant, H.
    [J]. CURRENT ONCOLOGY, 2014, 21 (06) : 337 - 339
  • [46] US guidelines published for the management of non-small-cell lung cancer
    Bonn, D
    [J]. LANCET, 1997, 350 (9075): : 417 - 417
  • [47] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Takayasu Kurata
    Isamu Okamoto
    Kenji Tamura
    Masahiro Fukuoka
    [J]. Investigational New Drugs, 2007, 25 : 499 - 504
  • [48] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Kurata, Takayasu
    Okamoto, Isamu
    Tamura, Kenji
    Fukuoka, Masahiro
    [J]. INVESTIGATIONAL NEW DRUGS, 2007, 25 (05) : 499 - 504
  • [49] ADVANCES IN SURGICAL STAGING AND THERAPY OF NON-SMALL-CELL LUNG-CANCER
    SUGARBAKER, DJ
    STRAUSS, GM
    [J]. SEMINARS IN ONCOLOGY, 1993, 20 (02) : 163 - 172
  • [50] Surgical outcomes in elderly non-small-cell lung cancer (NSCLC) patients
    Skrzypski, M
    Dziadziuszko, R
    Kobierska-Gulida, G
    Rzyman, W
    Zurek, W
    Skokowski, J
    Jassem, E
    Jassem, J
    [J]. LUNG CANCER, 2004, 45 : S48 - S48